PE(14:0/22:1(13Z))

Metabolite details

Identifier

RETPVUGMYRRYPF-SGFDTVKUSA-N

InChI Key

RETPVUGMYRRYPF-SGFDTVKUSA-N

IUPAC name

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] (Z)-docos-13-enoate

Preferred name

PE(14:0/22:1(13Z))

INN name

—

Synonym

—

ChEBI

CHEBI:170442

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii
• A multi-omics approach to study peroxisome proliferator-activated receptor mediated regulation of lipid metabolism in Atlantic cod (Gadus morhua)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Transcriptional differentiation of Trypanosoma brucei during in vitro acquisition of resistance to acoziborole
• Industrial by-products as a novel circular source of biocompatible extracellular vesicles
• Changes and correlations of intestinal flora and liver metabolite profiles in mice with gallstones
• Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
• Transcriptomic dynamics control rapid transition of core crop functions in 'lactating' pigeon
• Flow cytometry has a significant impact on the cellular metabolome (Lipidomic LC-MS assay)
• LION-web validation lipidomics experiments (FA-incorporation, membrane fluidty)

Observed in differential profiles

• Wild_type_vs_hfq
• Control_Plasma_vs_WY-14,643_Plasma
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• WT_vs_WT_Aco
• Brewer_Spend_Yeast_vs_Whey
• Control_vs_Lithogenic_Diet
• Normal_control_no_tumor_vs_FH_deficient_RCC
• Normal_control_no_tumor_vs_FH_deficient_RCC
• Male_19_days_vs_Male_1_day
• G1_Ctrl_vs_G2_Ab
• BSA_Control_vs_AA